The commercialisation of this medical procedure has been largely promoted through the constant need for organs because in general, the supply of organs is often lower than demand. In most cases, individuals tend to shy away from donating their organs to total strangers and this has influenced those who really need the organs to offer financial incentives to encourage reluctant individuals to donate.
The proponents of the commercialisation of transplants state that it makes it possible to satisfy the demand for organs in the healthcare system because individuals are often more than willing to donate their organs if they believe that they or their next of kin will likely gain some financial benefits from the procedure. Moreover, there are individuals who are often reluctant to donate their organs because of the fear of risking their health but with commercialisation; this fear tends to be put in the background because of the benefits that they are likely to receive (Budiani-Saberi and Delmonico 925). Those who are against the commercialisation of organ transplants believe that it cheapens the worth of human beings because individuals come to look upon their organs as commodities which can be used for the sake of gaining money rather than as basic parts of their bodies. Moreover, might make it possible for there to be a rise in organ trafficking because cartels will get involved in the business which will mean that certain individuals will donate their kidneys whether they like it or not. Therefore, the commercialisation of organ transplants is a new area in the medical field whose consequences have to be carefully studied by governments all over the world so that laws regulating it can be passed to ensure accountability in the procedure.
The sale of organs is an inevitable part of the medical procedures of the future and it is because of this inevitability that it should be allowed as early as possible. Allowing the sale of organs at such an early stage